Yinyi Biotech

Yinyi Biotech (Liaoning Yinyi Biological Technology) is a specialized medical device company based in Dalian, China, focusing on innovative interventional cardiology solutions. Established in 2004, the company is a pioneer in polymer-free drug-delivery technologies, which aim to improve long-term clinical outcomes by reducing inflammation associated with polymer carriers. Its flagship products include the Bingo® coronary drug-eluting balloon and the Yinyi® polymer-free drug-loaded coronary stent system, both of which utilize paclitaxel to treat coronary stenosis. The company is listed on China's New Third Board and has gained international recognition, notably receiving FDA Breakthrough Device Designation for three of its products in 2024. Yinyi Biotech maintains multiple GMP-certified manufacturing facilities and a robust research infrastructure, positioning itself as a leader in the next generation of cardiovascular interventions.